FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to use of 3,4,5-trimethoxy-N'(2,2,6,6-tetramethyl-piperidin-4-ylidene)benzohydrazide hydrochloride as an anxiolytic agent.
EFFECT: detecting expressed anxiolytic activity and anticompulsive effect of 3,4,5-trimethoxy-N'(2,2,6,6-tetramethyl-piperidin-4-ylidene)benzohydrazide hydrochloride.
1 cl, 1 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ACYLHYDRAZONE (2,3,4-TRIMETHOXY-N'-(8-METHYL-8-AZABICYCLO[3.2.1.]OCTANE-3-YLIDENE) BENZOHYDRAZIDE HYDROCHLORIDE), HAVING ANTIMIGRAINE AND ANXIOLYTIC ACTIVITY | 2016 |
|
RU2699658C2 |
COMPOUND OF 2,3,4-TRIMETHOXY-N-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLIDENE)BENZOHYDRAZIDE HYDROCHLORIDE WITH ANTISEROTONIN CEREBROVASCULAR AND ANTIMIGRAINE ACTIVITY | 2022 |
|
RU2803750C1 |
COMBINATION OF PIPERIDINE DERIVATIVE WITH PICAMILONE, HAVING ANTISEROTONIN AND ANTI-ISCHEMIC ACTIVITY | 2023 |
|
RU2822877C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
SUBSTITUTED 2-[2(3-OXOMORPHOLIN-4-YL)ETHYLTHIO]BENZIMIDAZOLES, WITH ANXIOLYTIC ACTIVITY | 2007 |
|
RU2373202C2 |
PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
DIPHENYLPHOSPHINO METHANE HYDRAZIDE, WHICH HAS BIOLOGICAL ACTIVITY, AND THE METHOD FOR ITS PREPARATION | 2021 |
|
RU2783121C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
AGENT FOR TREATMENT OF BRAIN ISCHEMIC INJURY | 2004 |
|
RU2288714C2 |
ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
Authors
Dates
2019-06-14—Published
2016-03-30—Filed